ITGB2 and pancreatic neoplasm: Further, to evaluate the effect of canertinib and afatinib on cell survival, colony formation assay was performed in CD18/HPAF (0.1-0.3×104 cells/well) and Capan-1 (0.1×104) pancreatic cancer cells.